+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hepatitis E Diagnostic Tests Market Size, Share & Trends Analysis Report By Type (ELISA HEV IgM Test, Rapid Diagnostics Test), By End-use (Hospitals, Blood Banks), By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • January 2025
  • Region: Global
  • Grand View Research
  • ID: 5990554
Description Jump to:
The global hepatitis E diagnostic tests market size was valued at USD 57.1 million in 2024 and is projected to witness a CAGR of 4.8% from 2025 to 2030. The growing prevalence of Hepatitis E globally, especially in developing regions, significantly drives the demand for diagnostic tests. As the awareness surrounding Hepatitis E increases due to public health campaigns and improved access to information, more individuals are seeking early detection and treatment. This heightened awareness is boosting the adoption of diagnostic tests, contributing to the market's expansion. Additionally, the emphasis on preventing outbreaks and improving healthcare infrastructure further stimulates the growth of the Hepatitis E diagnostic test market, with continued advancements in testing technology.

In addition, innovations in diagnostic technologies, such as advanced molecular techniques, rapid testing platforms, and point-of-care (POC) solutions, significantly enhance the detection of hepatitis E. These advancements offer faster, more accurate, cost-effective diagnostics, which are expected to increase market demand. The surge in preference for POC diagnostics, driven by the need for quick results in remote or resource-limited areas, further boosts market growth. As healthcare systems prioritize early diagnosis and timely interventions, the hepatitis E diagnostic tests market is poised for substantial expansion in the years ahead.

Global Hepatitis E Diagnostic Tests Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, the analyst has segmented the global hepatitis E diagnostic tests market report based on type, end-use, and region:

Type Outlook (Revenue, USD Million, 2018 - 2030)

  • ELISA HEV IgM Tests
  • ELISA HEV IgG Tests
  • Rapid Diagnostics Tests
  • Polymerase Chain Reaction (PCR)

End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals
  • Diagnostics Laboratories
  • Blood Banks
  • Others

Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Hepatitis E Diagnostic Tests Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
Chapter 4. Hepatitis E Diagnostic Tests Market: Type Business Analysis
4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. ELISA HEV IgM Tests
4.4.1. ELISA HEV IgM Tests Market, 2018 - 2030 (USD Million)
4.5. ELISA HEV IgG Tests
4.5.1. ELISA HEV IgG Tests Market, 2018 - 2030 (USD Million)
4.6. Rapid Diagnostics Tests
4.6.1. Rapid Diagnostics Tests Market, 2018 - 2030 (USD Million)
4.7. Polymerase Chain Reaction (PCR)
4.7.1. Polymerase Chain Reaction (PCR) Market, 2018 - 2030 (USD Million)
Chapter 5. Hepatitis E Diagnostic Tests Market: End Use Business Analysis
5.1. End Use Market Share, 2024 & 2030
5.2. End Use Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Hospitals market, 2018 - 2030 (USD Million)
5.5. Diagnostics Laboratories
5.5.1. Diagnostics Laboratories Market, 2018 - 2030 (USD Million)
5.6. Blood Banks
5.6.1. Blood Banks Market, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Hepatitis E Diagnostic Tests Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Canada Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. Mexico Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Insights
6.5.2.4. UK Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Insights
6.5.3.4. Germany Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Insights
6.5.4.4. France Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Regulatory Framework
6.5.5.3. Competitive Insights
6.5.5.4. Italy Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Regulatory Framework
6.5.6.3. Competitive Insights
6.5.6.4. Spain Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamics
6.5.7.2. Regulatory Framework
6.5.7.3. Competitive Insights
6.5.7.4. Denmark Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.8. Sweden
6.5.8.1. Key Country Dynamics
6.5.8.2. Regulatory Framework
6.5.8.3. Competitive Insights
6.5.8.4. Norway Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Regulatory Framework
6.5.9.3. Competitive Insights
6.5.9.4. Sweden Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Insights
6.6.2.4. Japan Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Insights
6.6.3.4. China Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Insights
6.6.4.4. India Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Insights
6.6.5.4. South Korea Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Insights
6.6.6.4. Australia Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Insights
6.6.7.4. Thailand Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Framework
6.8.4.3. Competitive Insights
6.8.4.4. UAE Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Regulatory Framework
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Wantai BioPharm
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. MP Biomedicals LLP
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. PerkinElmer, Inc
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Dia.Pro Diagnostic Bioprobes srl
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. ELITechGroup
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Primerdesign Ltd
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. F. Hoffmann-La Roche Ltd
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Mikrogen GmbH
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Altona Diagnostics
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. Fortress Diagnostics
7.5.10.1. Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global hepatitis E diagnostic tests market, by region, 2018 - 2030 (USD Million)
Table 4. Global hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 5. Global hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 6. North America hepatitis E diagnostic tests market, by country, 2018 - 2030 (USD Million)
Table 7. North America hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 8. North America hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 9. U.S. hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 10. U.S. hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 11. Canada hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 12. Canada hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 13. Mexico hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 14. Mexico hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 15. Europe hepatitis E diagnostic tests market, by country, 2018 - 2030 (USD Million)
Table 16. Europe hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 17. Europe hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 18. UK hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 19. UK hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 20. Germany hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 21. Germany hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 22. France hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 23. France hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 24. Italy hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 25. Italy hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 26. Spain hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 27. Spain hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 28. Denmark hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 29. Denmark hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 30. Sweden hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 31. Sweden hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 32. Norway hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 33. Norway hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 34. Asia Pacific hepatitis E diagnostic tests market, by country, 2018 - 2030 (USD Million)
Table 35. Asia Pacific hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 36. Asia Pacific hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 37. Japan hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 38. Japan hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 39. China hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 40. China hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 41. India hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 42. India hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 43. Australia hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 44. Australia hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 45. South Korea hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 46. South Korea hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 47. Thailand hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 48. Thailand hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 49. Latin America hepatitis E diagnostic tests market, by country, 2018 - 2030 (USD Million)
Table 50. Latin America hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 51. Latin America hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 52. Brazil hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 53. Brazil hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 54. Argentina hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 55. Argentina hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 56. Middle East & Africa hepatitis E diagnostic tests market, by country, 2018 - 2030 (USD Million)
Table 57. Middle East & Africa hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 58. Middle East & Africa hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 59. South Africa hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 60. South Africa hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 61. Saudi Arabia hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 62. Saudi Arabia hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 63. UAE hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 64. UAE hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
Table 65. Kuwait hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
Table 66. Kuwait hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Hepatitis E diagnostic tests market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Type and end use outlook (USD Million)
Fig. 11 Competitive landscape
Fig. 12 Hepatitis E diagnostic tests market dynamics
Fig. 13 Hepatitis E diagnostic tests market: Porter’s five forces analysis
Fig. 14 Hepatitis E diagnostic tests market: PESTLE analysis
Fig. 15 Hepatitis E diagnostic tests market: Type segment dashboard
Fig. 16 Hepatitis E diagnostic tests market: Type market share analysis, 2024 & 2030
Fig. 17 ELISA HEV IgM tests market, 2018 - 2030 (USD Million)
Fig. 18 ELISA HEV IgG tests market, 2018 - 2030 (USD Million)
Fig. 19 Rapid diagnostics tests market, 2018 - 2030 (USD Million)
Fig. 20 Polymerase Chain Reaction (PCR) market, 2018 - 2030 (USD Million)
Fig. 21 Hepatitis E diagnostic tests market: End use segment dashboard
Fig. 22 Hepatitis E diagnostic tests market: End use market share analysis, 2024 & 2030
Fig. 23 Hospitals market, 2018 - 2030 (USD Million)
Fig. 24 Diagnostics laboratories market, 2018 - 2030 (USD Million)
Fig. 25 Blood banks market, 2018 - 2030 (USD Million)
Fig. 26 Others market, 2018 - 2030 (USD Million)
Fig. 27 Hepatitis E diagnostic tests market revenue, by region
Fig. 28 Regional marketplace: Key takeaways
Fig. 29 Regional marketplace: Key takeaways
Fig. 30 North America hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 31 U.S. country dynamics
Fig. 32 U.S. hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 33 Canada country dynamics
Fig. 34 Canada hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 35 Mexico country dynamics
Fig. 36 Mexico hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 37 Europe hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 38 UK country dynamics
Fig. 39 UK hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 40 Germany country dynamics
Fig. 41 Germany hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 42 France country dynamics
Fig. 43 France hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 44 Italy country dynamics
Fig. 45 Italy hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 46 Spain country dynamics
Fig. 47 Spain hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 48 Denmark country dynamics
Fig. 49 Denmark hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 50 Sweden country dynamics
Fig. 51 Sweden hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 52 Norway country dynamics
Fig. 53 Norway hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 54 Asia Pacific hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 55 Japan country dynamics
Fig. 56 Japan hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 57 China country dynamics
Fig. 58 China hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 59 India country dynamics
Fig. 60 India hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 61 Australia country dynamics
Fig. 62 Australia hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 63 South Korea country dynamics
Fig. 64 South Korea hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 65 Thailand country dynamics
Fig. 66 Thailand hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 67 Latin America hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 68 Brazil country dynamics
Fig. 69 Brazil hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 70 Argentina country dynamics
Fig. 71 Argentina hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 72 MEA hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 73 South Africa country dynamics
Fig. 74 South Africa hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 75 Saudi Arabia country dynamics
Fig. 76 Saudi Arabia hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 77 UAE country dynamics
Fig. 78 UAE hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 79 Kuwait Key country dynamicss
Fig. 80 Kuwait hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
Fig. 81 Company categorization
Fig. 82 Company market position analysis
Fig. 83 Strategic framework

Companies Mentioned

  • Wantai BioPharm
  • MP Biomedicals LLP
  • PerkinElmer, Inc
  • Dia.Pro Diagnostic Bioprobes srl
  • ELITechGroup
  • Primerdesign Ltd
  • F. Hoffmann-La Roche Ltd
  • Mikrogen GmbH
  • Altona Diagnostics
  • Fortress Diagnostics

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedJanuary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 57.1 Million
Forecasted Market Value ( USD ) by 2030 $ 75.6 Million
Compound Annual Growth Rate4.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Hepatitis Test Solution/Diagnosis Market by Disease Type, Technology, End-User - Global Forecast 2025-2030 - Product Image

Hepatitis Test Solution/Diagnosis Market by Disease Type, Technology, End-User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Viral Hepatitis and Retrovirus Diagnostic Tests - Global Strategic Business Report - Product Image

Viral Hepatitis and Retrovirus Diagnostic Tests - Global Strategic Business Report

  • Report
  • 168 Pages
  • Global
From
Hepatitis Test Solution/Diagnosis - Global Strategic Business Report - Product Image

Hepatitis Test Solution/Diagnosis - Global Strategic Business Report

  • Report
  • 88 Pages
  • Global
From
Infectious Disease In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents, Software), Technology, Application, Test Location, Region, and Segment Forecasts, 2024-2030 - Product Image

Infectious Disease In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents, Software), Technology, Application, Test Location, Region, and Segment Forecasts, 2024-2030

  • Report
  • 190 Pages
  • Global
From
Hepatitis Diagnostic Tests Market Report by Test Type (Blood Tests, Imaging Test, Liver Biopsy), and Region 2025-2033 - Product Image

Hepatitis Diagnostic Tests Market Report by Test Type (Blood Tests, Imaging Test, Liver Biopsy), and Region 2025-2033

  • Report
  • 136 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.